• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

    145.04 +13.37 (+10.15%)
    Streaming Delayed Price Updated: 12:06 PM EDT, Apr 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,892,723
    Open 146.22
    Bid (Size) 144.80 (400)
    Ask (Size) 145.28 (100)
    Prev. Close 131.67
    Today's Range 141.61 - 150.00
    52wk Range 34.00 - 155.70
    Shares Outstanding 106,313,250
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Revolution Medicines Has a Market Cap of $29 Billion and Generates No Revenue. Here's Why Its Valuation May Not Be as Ridiculous as It Seems ↗
    The company has multiple drugs in its pipeline that could generate billions in revenue. 
    Via The Motley Fool
    News headline image
    Revolution Medicines (RVMD): The New Titan of the RAS Pathway (2026 Research Feature)
    As of April 15, 2026, the biotechnology sector is witnessing a paradigm shift in precision oncology, spearheaded by Revolution Medicines, Inc. (Nasdaq: RVMD). Once considered a high-risk clinical-stage... 
    Via Finterra
    Topics Initial Public Offering

    Performance

    YTD
    +83.5%
    +83.5%
    1 Month
    +56.4%
    +56.4%
    3 Month
    +48.3%
    +48.3%
    6 Month
    +150.1%
    +150.1%
    1 Year
    +249.7%
    +249.7%

    More News

    Read More
    News headline image
    The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
    Via Finterra
    Topics Economy Initial Public Offering Intellectual Property
    Revolution Medicines Inc (NASDAQ:RVMD) Reports Q4 2025 Earnings Miss, Reaffirms Key Phase 3 Timeline ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Which stocks are moving before the opening bell on Monday? ↗
    Via Chartmill
    News headline image
    Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer
    From Revolution Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? ↗
    Via The Motley Fool
    News headline image
    This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Derivatives ETFs Regulatory Compliance
    News headline image
    This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year ↗
    Via The Motley Fool
    News headline image
    Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. ↗
    Via The Motley Fool
    News headline image
    Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? ↗
    Via The Motley Fool
    News headline image
    Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Revolution Medicines (RVMD) Earnings Transcript ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Revolution Medicines, Inc. - Common Stock publicly traded?
    Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.
    What exchange does Revolution Medicines, Inc. - Common Stock trade on?
    Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?
    The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market
    What is the current price of Revolution Medicines, Inc. - Common Stock?
    The current price of Revolution Medicines, Inc. - Common Stock is 145.04
    When was Revolution Medicines, Inc. - Common Stock last traded?
    The last trade of Revolution Medicines, Inc. - Common Stock was at 04/28/26 12:06 PM ET
    What is the market capitalization of Revolution Medicines, Inc. - Common Stock?
    The market capitalization of Revolution Medicines, Inc. - Common Stock is 15.42B
    How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?
    Revolution Medicines, Inc. - Common Stock has 15B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.